MCK vs VEEV vs HSIC Stock Comparison

Mckesson, Veeva Systems and Henry Schein Prices as of Oct 23, 2026 Peers: Industry group
MCK Mckesson Corp
$1,001.01 +13.6% 1M +26.2% 1Y
Market cap
$117.56B
P/E
25.6x
Revenue (TTM)
$410.98B
Div. yield
0.00%
Drug Distribution Healthcare
4 wins
VEEV Veeva Systems Inc
$322.91 +19.2% 1M +10.8% 1Y
Market cap
$51.67B
P/E
50.9x
Revenue (TTM)
$3.46B
Div. yield
–
Healthcare IT Technology
3 wins
HSIC Henry Schein Inc
$84.96 -0.1% 1M +33.6% 1Y
Market cap
$9.59B
P/E
23.8x
Revenue (TTM)
$13.60B
Div. yield
–
Drug Distribution Healthcare
4 wins

Head to Head

11 decided of 12

Mckesson leads on 4 of the 12 questions below (Mckesson 4, Henry Schein 4, Veeva Systems 3). Which ones matter depends on what you are buying for; a cheap multiple and slow growth often come together.

QuestionMCKVEEVHSICLeader
Larger companyMarket capitalisation $117.56B $51.67B $9.59B MCK
Cheaper on earningsLower P/E, profitable companies only 25.6x 50.9x 23.8x HSIC
Cheaper on forward earningsLower price / next fiscal year consensus EPS 21.2x 36.0x 14.8x HSIC
Faster revenue growthRevenue growth, trailing twelve months +8.8% +16.5% +6.5% VEEV
More profitableNet margin, trailing twelve months 1.1% 29.3% 3.0% VEEV
Better return on capitalReturn on invested capital 107.9% — 7.1% MCK
Less leveragedLower net debt / EBITDA 0.6x — 3.3x MCK
Higher dividend yieldTrailing dividend yield 0.00% 0.00% 0.00% –
Better 1-year returnPrice return, last 12 months +26.2% +10.8% +33.6% HSIC
Better 5-year returnAnnualised price return, 5 years +36.8%/yr +0.1%/yr +1.2%/yr MCK
Less volatileAnnualised volatility, 1 year 30.6% 42.8% 25.6% HSIC
Higher overall scoreMean of the five percentile scores vs peers 60/100 68/100 55/100 VEEV

Percentile Scorecard

MCKVEEVHSIC

Each axis is the mean percentile of its metrics against the company's industry group. 100 is the best in the group, 50 the middle.

Scores by Axis

AxisMCKVEEVHSIC
Valuation 54 #12 of 25 35 #59 of 90 33 #17 of 25
Growth 65 #9 of 24 74 #22 of 82 39 #15 of 24
Profitability 65 #9 of 24 87 #11 of 77 83 #5 of 24
Financial Health 52 #13 of 26 95 #6 of 96 20 #21 of 26
Shareholder Returns 63 #7 of 17 49 #28 of 54 100 #1 of 17
Overall 60 68 55
  • MCK ranked among 27 companies in Healthcare Payers and Distributors
  • VEEV ranked among 99 companies in Vertical Software
  • HSIC ranked among 27 companies in Healthcare Payers and Distributors

Price Performance

Price return, split-adjusted, before dividends. Click a name to hide or show it.

Returns

PeriodMCKVEEVHSICSPY
1 month +13.6%+19.2%-0.1% -1.0%
3 months +19.1%+73.3%-0.6% +2.9%
6 months +20.9%+100.4%+9.6% +6.4%
Year to date +22.0%+44.7%+12.4% +11.4%
1 year +26.2%+10.8%+33.6% +13.1%
3 years +121.4%+63.8%+26.2% +79.4%
3 years, per year +30.4%+17.9%+8.1% +21.5%
5 years +378.7%+0.7%+6.3% +67.7%
5 years, per year +36.8%+0.1%+1.2% +10.9%
10 years +521.6%+732.0%+42.0% +255.2%
10 years, per year +20.1%+23.6%+3.6% +13.5%

Risk

MeasureMCKVEEVHSICSPY
Volatility, 1Y 30.6%42.8%25.6% 12.7%
Downside volatility, 1Y 27.4%40.4%24.1% 12.7%
Beta vs S&P 500, 1Y -0.250.580.46 1.00
Return / volatility, 1Y 0.860.251.31 1.03
Max drawdown, 5Y -27.2%-53.2%-32.7% -25.4%
From 52-week high -2.8%0.0%-6.5% -2.5%
52-week high $1,030.18$322.91$90.86 $779.14
52-week low $725.17$151.43$62.32 $631.97

Valuation History

Weekly multiples on trailing twelve-month fundamentals. Negative or extreme readings (a loss year, a collapsed denominator) are left out so the chart stays readable.

MultipleMCKVEEVHSIC
P/E now vs peer median 25.9xmedian 24.5x 51.7xmedian 42.7x 23.9xmedian 24.5x
P/S now vs peer median 0.3xmedian 0.3x 15.1xmedian 2.7x 0.7xmedian 0.3x
EV/EBITDA now vs peer median 16.7xmedian 14.4x 41.2xmedian 19.0x 12.7xmedian 14.4x
P/FCF now vs peer median 18.2xmedian 15.8x 31.4xmedian 19.6x 16.7xmedian 15.8x
P/B now vs peer median -27.5xmedian 2.5x 7.0xmedian 1.8x 2.5xmedian 2.5x
PEG now vs peer median 2.16median 1.35 2.25median 1.75 50.09median 1.35

Financial History

Reported figures by fiscal period, placed on the calendar year (or quarter) each period ended in, so companies with different fiscal years line up.

Trailing twelve monthsMCKVEEVHSIC
Revenue $410.98B $3.46B $13.60B
Gross profit $14.96B $2.59B $4.26B
Operating income $6.50B $1.03B $680.00M
Net income $5.30B $1.01B $426.00M
Free cash flow $6.42B $1.67B $569.00M
R&D – $821.92M –
EPS (diluted) $38.52 $6.15 $3.52
Cash & equivalents $5.16B $1.81B –
Total debt $9.73B – $3.46B
Shares (diluted) 119.20M 165.06M 114.39M
Enterprise value $101.45B $23.91B $9.43B

All Metrics

58 metrics · best in bold

Bold marks the best reading: the lowest positive value for multiples, leverage and payout, the highest for everything else. The bar under each value is its percentile against that company's own peers. Hover a value for its rank and the peer median.

Valuation

12 metrics
MetricMCKVEEVHSIC
P/E 25.9x 51.7x 23.9x
P/FCF 18.2x 31.4x 16.7x
P/Operating cash flow 17.0x 31.4x 13.6x
P/S 0.3x 15.1x 0.7x
P/B -27.5x 7.0x 2.5x
P/Tangible book -14.1x 7.1x 3.3x
EV/EBITDA 16.7x 41.2x 12.7x
EV/EBIT 18.7x 43.5x 18.8x
EV/Revenue 0.3x 13.0x 0.9x
EV/FCF 18.9x 27.0x 22.5x
EV/Operating cash flow 17.7x 27.0x 18.3x
PEG (3Y EPS CAGR) 2.16 2.25 50.09

Growth

14 metrics
MetricMCKVEEVHSIC
Revenue growth (1Y) 8.8% 16.5% 6.5%
Revenue CAGR (3Y) 13.1% 15.7% 2.6%
Gross profit growth (1Y) 11.2% 15.5% 6.4%
Gross profit CAGR (3Y) 6.6% 18.0% 3.4%
Operating income growth (1Y) 46.6% 29.5% 6.6%
Operating income CAGR (3Y) 13.5% 37.8% 1.1%
Net income growth (1Y) 58.1% 25.3% 6.0%
Net income CAGR (3Y) 10.7% 23.4% -4.5%
EPS growth (1Y) 52.8% 27.3% 11.1%
EPS CAGR (3Y) 12.0% 22.9% 0.5%
Operating cash flow growth (1Y) 4.7% 23.4% 36.7%
Operating cash flow CAGR (3Y) 10.7% 19.5% 2.3%
Free cash flow growth (1Y) 6.8% 23.4% 50.1%
Free cash flow CAGR (3Y) 11.3% 19.5% 2.3%

Profitability

14 metrics
MetricMCKVEEVHSIC
Gross margin 3.6% 75.0% 31.3%
EBITDA margin 1.8% 31.6% 7.4%
Operating margin 1.6% 29.9% 5.0%
Pretax margin 1.6% 38.4% 4.1%
Net margin 1.1% 29.3% 3.0%
FCF margin 1.6% 48.2% 4.2%
Operating cash flow margin 1.7% 48.2% 5.1%
Return on equity – 13.8% 11.0%
Return on assets 6.2% 11.2% 3.8%
Return on invested capital 107.9% – 7.1%
Return on capital employed 43.4% 13.5% 8.7%
Asset turnover 4.8x 0.4x 1.2x
Cash conversion (OCF / net income) 1.3x 1.6x 1.6x
Stock comp / revenue – 14.3% 0.3%

Financial Health

11 metrics
MetricMCKVEEVHSIC
Debt / assets 11.0% – 30.4%
Debt / equity -2.3x – 0.9x
Net debt / EBITDA 0.6x – 3.3x
Debt / FCF 1.5x – 6.1x
Liabilities / assets 104.8% 18.0% 66.5%
Equity / assets -4.8% 82.0% 33.5%
Interest coverage 23.6x – 4.3x
Current ratio 0.9x 5.5x 1.3x
Quick ratio 0.5x 5.4x 0.6x
Cash ratio 0.1x 5.0x 0.0x
Altman Z-score 5.91 21.63 2.66

Shareholder Returns

7 metrics
MetricMCKVEEVHSIC
Dividend yield 0.3% – –
Net buyback yield 5.7% 0.7% 7.6%
Shareholder yield 6.0% 0.7% 7.6%
Payout ratio (earnings) 7.4% – –
Payout ratio (FCF) 6.1% – –
Dividend growth (1Y) 11.3% – –
Dividend CAGR (3Y) 10.0% – –

Analyst Estimates

Solid lines are reported fiscal-year results; dashed lines are the consensus for the years ahead. Hover a year for the analysts' high and low, and how each result compared with its estimate.

ConsensusMCKVEEVHSIC
Forward P/E 21.2xFY2026 36.0xFY2026 14.8xFY2026
EPS, next fiscal year $47.14FY2026 $8.97FY2026 $5.75FY2026
EPS growth, next FY +20.5%FY2026 +10.7%FY2026 +15.7%FY2026
EPS growth, the year after +11.1% +16.8% +8.2%
Revenue, next fiscal year $444.51BFY2026 $3.60BFY2026 $13.38BFY2026
Revenue growth, next FY +10.2%FY2026 +12.5%FY2026 +1.5%FY2026
Revenue growth, the year after +1.4% +17.3% +4.9%

Institutional Ownership

13F filings, quarter ended Jun 30, 2026
HoldersMCKVEEVHSIC
Held by institutions 89.1% 88.8% 100.0%
Institutions holding 2,007 1,056 564
Change in shares held, QoQ -0.7% +5.7% +2.1%
Institutions buying 879 586 245
Institutions selling 791 358 216
Buyers to sellers 1.11 1.64 1.13

Return Correlation

Daily returns, last 12 months

1.00 means two stocks move in lockstep, 0 that they move independently. Pairs below about 0.5 diversify each other.

MCKVEEVHSIC
MCK 1.00 -0.04 0.30
VEEV -0.04 1.00 0.12
HSIC 0.30 0.12 1.00

Add a Peer

Largest companies in the same industry

Related Comparisons

Frequently Asked Questions

Which is bigger, MCK, VEEV and HSIC?

Mckesson (MCK) is the largest by market capitalisation: Mckesson (MCK) $117.56B, Veeva Systems (VEEV) $51.67B, Henry Schein (HSIC) $9.59B.

Which stock is cheaper, MCK, VEEV and HSIC?

Henry Schein (HSIC) trades on the lowest price-to-earnings ratio (Mckesson (MCK) 25.6x, Veeva Systems (VEEV) 50.9x, Henry Schein (HSIC) 23.8x). On next year's consensus earnings, Henry Schein (HSIC) is cheapest (Mckesson (MCK) 21.2x, Veeva Systems (VEEV) 36.0x, Henry Schein (HSIC) 14.8x). A lower multiple can reflect slower expected growth, so read it next to the growth figures.

Which company is growing faster?

Veeva Systems (VEEV) grew revenue fastest over the trailing twelve months: Mckesson (MCK) +8.8%, Veeva Systems (VEEV) +16.5%, Henry Schein (HSIC) +6.5%.

Which company is more profitable?

Veeva Systems (VEEV) has the highest net margin (Mckesson (MCK) 1.1%, Veeva Systems (VEEV) 29.3%, Henry Schein (HSIC) 3.0%). On return on invested capital, Mckesson (MCK) leads (Mckesson (MCK) 107.9%, Henry Schein (HSIC) 7.1%).

Which stock has performed better?

Over the past year Henry Schein (HSIC) returned the most: Mckesson (MCK) +26.2%, Veeva Systems (VEEV) +10.8%, Henry Schein (HSIC) +33.6%. Over five years, Mckesson (MCK) compounded fastest (Mckesson (MCK) +36.8%/yr, Veeva Systems (VEEV) +0.1%/yr, Henry Schein (HSIC) +1.2%/yr). Returns are price only, before dividends.

Which pays a higher dividend?

Only one of these companies pays a dividend: Mckesson (MCK) 0.00%, Veeva Systems (VEEV) 0.00%, Henry Schein (HSIC) 0.00%. Veeva Systems (VEEV) and Henry Schein (HSIC) pays no regular dividend.

Which stock is riskier?

By one-year price volatility, Henry Schein (HSIC) has been the steadiest (Mckesson (MCK) 30.6%, Veeva Systems (VEEV) 42.8%, Henry Schein (HSIC) 25.6%). Volatility measures how widely the price swings, not the risk of the business.

Which is the better stock, MCK, VEEV and HSIC?

There is no single answer; it depends on what you are buying for. On the 12 head-to-head measures on this page, Mckesson (MCK) leads on 4. Business Quant does not give investment advice; use the comparison as a starting point for your own research.

Data from SEC filings, exchange prices and consensus estimates, via Business Quant. Percentile scores compare each company with its own peer group, so two companies' scores are each relative to different peers unless you rank against the whole market. Price returns exclude dividends. Nothing on this page is investment advice.